Apolipoprotein E polymorphism and its relation to plasma lipids in coronary heart disease

Indian Journal of Medical Sciences

Volumn 62, Issue 3, 2008, Pages 105-112

  Singh, P ^a   Singh, M ^a   Bhatnagar, D ^a   Kaur, T ^b   Gaur, S ^c  

^a PUNJABI UNIVERSITY   (India)

^b City Medsave Hospital   (India)

^c Sai Cardio Clinic   (India)

Author keywords

APOE; APOE polymorphism; Apolipoprotein E; Coronary heart disease; Punjab

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 41849140785     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.39613     Document Type: Article

References (28)

1. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.
2. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein (a) and cardiovascular risk in Indians, Malays and Chinese in Singapore. J Epidemiol Community Health 1997;51:394-9.
3. Wander GS, Khurana SB, Gulati R, Sachar RK, Gupta RK, Khurana S, et al. Epidemiology of coronary heart disease in a rural Punjab population-prevalence and correlation with various risk factors. Indian Heart J 1994;46:319-23.
4. Wang XL, McCredie RM, Wilcken DE. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol 1995;15:1030-4.
5. Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-9.
6. Wilson PW, Schaefer EJ, Larson MG ordovas JM. Apolipoprotein E alleles and risk of coronary artery disease: A meta analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-5.
7. Mahley RW, Huang Y, Weisgraber KH. Putting cholesterol in its place: ApoE and reverse cholesterol transport. J Clin Invest 2006;116:1226-9.
8. Allan CM, Walker D, Segrest JP, Taylor JM. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I and C-II gene locus. Genomics 1995;28:291-300.
9. Hui DY, Innerarity TL, Milne RW, Marcel YL, Mahley RW. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extra hepatic lipoprotein receptors: A process independent of apolipoprotein B48. J Biol Chem 1984;259:15060-8.
10. Sing CF, Davignon J. Role of Apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37:268-85.
11. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
12. Dallongeville J, Lussier-cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: A meta analysis. J Lipid Res 1992;33:447-54.
13. Singh P, Singh M, Gerdes U, Mastana SS. Apolipoprotein E polymorphism in India: High APOE*E3 allele frequency in Ramgarhia of Punjab. Anthrop Anz 2001;59:27-34.
14. Singh PP, Singh M, Mastana SS. Genetic variation of apolipoproteins in North Indians. Hum Biol 2002;74:673-82.
15. Prineas JR, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings. John Wright PSG Inc: Boston, Bristol, London; 1982.
16. Rose GA, Blackburn H, Gillium FF, Prineas RJ. Cardiovascular survey methods. WHO: Geneva; 1982.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8.
19. Singh PP, Naz I, Gilmour A, Singh M, Mastana S. Association of APOE (HhaI) and ACE (I/D) gene polymorphism with type 2 diabetes mellitus in North West India. Diab Res Clin Pract 2006;74:95-102.
20. Singh PP, Singh M, Mastana SS. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 2006;33:279-308.
21. Kuusi T, Nieminen MS, Ehnholm C, Yki-Jarvinen H, Valle M, Nikkila EA, et al. Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989;9:237-41.
22. Corbo RM, Vilardo T, Ruggeri M, Gemma AT, Scacchi R. Apolipoprotein E genotype and plasma levels in coronary artery disease: A case-control study in the Italian population. Clin Biochem 1999;32:217-22.
23. Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, Osgood D, et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001;154:529-37.
24. de Knijff P, Jansen H, Lie KI, Havekes LM. Apolipoprotein epsilon 4 and coronary artery disease. Lancet 1992;340:1351.
25. Damaraju S, Yu QT, Safavi F, Marian AJ. Apolipoprotein epsilon 4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;75:1181-5.
26. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world: Is ApoE*4 a 'thrifty' allele? Ann Hum Genet 1999;63:301-10.
27. Gerdes LU. The common polymorphism of Apolipoprotein E: Geographical aspects and new pathophysiological relations. Clin Chem Lab Med 2003;41:628-31.
28. Luthra K, Bharghav B, Chabbra S, Das N, Misra A, Agarwal DP, et al. Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: Phenotype distribution and relation to serum lipids and lipoproteins. Mol Cell Biochem 2002;232:97-102.